Markets.com Logo

ALLO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.0334$
  • Previous Close
    1.123$
  • 52 Week Change
    2.92$
  • Day Range
    -0.09$
  • 52 Week High/Low
    0.8621$ - 3.78$
  • Dividend Per Share
    --
  • Market cap
    235 M$
  • EPS
    -0.23
  • Beta
    0.358
  • Volume
    --

About

ALLO.US represents Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (alloCAR T) cell therapy for cancer. Their primary focus is on creating off-the-shelf CAR T cell therapies that can be readily available to a broader patient population, addressing the limitations of autologous CAR T therapies which are patient-specific and require lengthy manufacturing times. Allogene is currently evaluating several alloCAR T candidates in clinical trials for various hematological malignancies and solid tumors. The company's progress is closely watched by investors and the medical community for its potential to revolutionize cancer treatment.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

A specific example of the explanation could be included. Company Performance: ALLO.US's financial results, including revenue, profit, and growth rate, significantly impact its stock price. Strong earnings usually lead to price increases.

Industry Trends: Trends in the biotech and pharmaceutical industries, such as new drug approvals, market demand, and competition, influence investor sentiment and ALLO.US's valuation. For example, increased demand for gene therapies could boost the stock.

Clinical Trial Results: The outcomes of ALLO.US's clinical trials for its drug candidates are crucial. Positive results generally lead to stock price surges, while negative results cause declines.

Regulatory Approvals: Regulatory decisions by agencies like the FDA regarding ALLO.US's products have a direct impact. Approval of a key drug can dramatically increase the stock price.

Market Conditions: Overall market conditions, including economic growth, interest rates, and investor sentiment, can affect ALLO.US's stock. A bull market usually lifts most stocks, while a bear market has the opposite effect.

Competitor Activity: Actions by competitors, such as the launch of a competing product or a merger, can affect ALLO.US's market share and stock price.

News and Events: Company-specific news, such as partnerships, acquisitions, or management changes, and broader economic events impact investor confidence and the stock price.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--